Basic Info

Vertex Pharmaceuticals Inc (VRTX) - Symdeko / Symkevi Revenue is at a current level of 0.000, down from 27.80M last quarter and down from 30.60M one year ago. This is a change of -100.0% from last quarter and -100.0% from one year ago.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 0.00
Latest Period Mar 2024
Last Updated Jul 31 2024, 08:44 EDT
Average Growth Rate -71.54%
Value from Last Quarter 27.80M
Change from Last Quarter -100.0%
Value from 1 Year Ago 30.60M
Change from 1 Year Ago -100.0%
Frequency Quarterly
Unit USD
Adjustment N/A

Historical Data

View and export this data back to 2019. Upgrade now.
Date Value
March 31, 2024 0.00
December 31, 2023 27.80M
September 30, 2023 33.40M
June 30, 2023 31.20M
March 31, 2023 30.60M
December 31, 2022 34.30M
September 30, 2022 38.20M
June 30, 2022 42.70M
March 31, 2022 64.80M
Date Value
December 31, 2021 80.00M
September 30, 2021 81.00M
June 30, 2021 134.00M
March 31, 2021 125.00M
December 31, 2020 128.00M
September 30, 2020 156.00M
June 30, 2020 172.00M
March 31, 2020 173.00M
December 31, 2019 332.00M

Basic Info

Vertex Pharmaceuticals Inc (VRTX) - Symdeko / Symkevi Revenue is at a current level of 0.000, down from 27.80M last quarter and down from 30.60M one year ago. This is a change of -100.0% from last quarter and -100.0% from one year ago.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 0.00
Latest Period Mar 2024
Last Updated Jul 31 2024, 08:44 EDT
Average Growth Rate -71.54%
Value from Last Quarter 27.80M
Change from Last Quarter -100.0%
Value from 1 Year Ago 30.60M
Change from 1 Year Ago -100.0%
Frequency Quarterly
Unit USD
Adjustment N/A

Related Securities

Symbol Name Change %
VRTX Vertex Pharmaceuticals Inc 0.72%
Quickflows